(1 - 27 von 27
)
Moximed closes $33 million financing roundGilde Healthcare
gildehealthcare.com
The new capital will support the company's efforts to gain FDA approval of the KineSpring System and grow commercial sales in Europe,” stated CEO Kevin Sidow. “ ... “This financing round is timely, as we are completing the primary endpoint follow-up for our FDA pivotal study this month,” said CEO Kevin Sidow.
Shock absorbers for the human body? Implant could help ...MedCity News
medcitynews.com
— ... technology (you guessed it), and Moximed is at work to apply the unloading concept to other joints, President and CEO Kevin Sidow said.
sortiert nach Relevanz / Datum